Oculis Holding AG (OCS) Payables (2021 - 2026)
Oculis Holding AG's (OCS) quarterly Payables came in at $5.7 million in Q1 2026, up 18.64% year-on-year from $4.8 million in Q1 2025, and up 154.94% quarter-over-quarter from $2.3 million in Q4 2025.
Oculis Holding AG (OCS) Payables (2021 - 2026) Analysis & Trends
Oculis Holding AG's Payables history runs 6 years deep, the most recent figure standing at $5.7 million for Q1 2026.
- On a quarterly basis, Payables rose 18.64% year-over-year to $5.7 million in Q1 2026; TTM through Mar 2026 was $5.7 million, a 18.64% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, down 67.47% from the prior year.
- Payables grew to $5.7 million in Q1 2026 per OCS's latest filing, from $2.3 million in the prior quarter.
- Across five years, Payables topped out at $8.6 million in Q4 2023 and bottomed at $1.3 million in Q1 2024.
- The 5-year median for Payables is $4.4 million (2023), against an average of $4.4 million.
- Across the five-year window, Payables surged 349.18% in 2022 and slumped 72.97% in 2025, its largest moves.
- Year by year, Payables stood at $4.0 million in 2022, then surged by 113.34% to $8.6 million in 2023, then declined by 21.74% to $6.7 million in 2024, then slumped by 66.4% to $2.3 million in 2025, then jumped by 154.94% to $5.7 million in 2026.
- Per Business Quant, the three latest OCS Payables figures stand at $5.7 million (Q1 2026), $2.3 million (Q4 2025), and $1.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.69 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 80.54 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 126.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.74 Mn |
| Dec 31, 2025 | 2.25 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 4.84 Mn |
| Dec 31, 2024 | 6.70 Mn |
| Sep 30, 2024 | 5.65 Mn |
| Jun 30, 2024 | 3.52 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 8.56 Mn |
| Sep 30, 2023 | 7.60 Mn |
| Jun 30, 2023 | 4.36 Mn |
| Dec 31, 2022 | 4.01 Mn |
| Dec 31, 2021 | 893,629.73 |